MRD Eradication Should be the Therapeutic Goal in Mantle Cell Lymphoma and May Enable Tailored Treatment Approaches: Results of the Intergroup Trials of the European MCL Network
2014; Elsevier BV; Volume: 124; Issue: 21 Linguagem: Inglês
10.1182/blood.v124.21.147.147
ISSN1528-0020
AutoresChristiane Pott, Elizabeth Macintyre, Marie‐Hélène Delfau‐Larue, Vincent Ribrag, Michael Unterhalt, Michael Kneba, Wolfgang Hiddemann, Martin Dreyling, Olivier Hermine, Eva Hoster,
Tópico(s)Chronic Lymphocytic Leukemia Research
Referência(s)